Skip to Main Content

Paper Details

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in <i>PBRM1</i>-Mutated Human Chordoma Xenograft.
Cancers (Basel)
11
2022
Author NameAffiliation
Julien Masliah-PlanchonInstitut Curie, University of Paris Saclay
Franck BourdeautInstitut Curie
  • 1 - 2

Datasets

Release 1.2